- MRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Mirati Therapeutics (MRTX) 8-K6 Jun 22Presentation marks first clinical dataset with a KRASG12C-inhibitor in patients with active, untreated CNS metastasesFinancial data
Company Profile